Oppenheimer Upgrades Exelixis (EXEL) to Outperform
Oppenheimer upgraded Exelixis (NASDAQ: EXEL) from Perform to Outperform with a price target of $40.00.Analyst Leah Rush ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
